Lake Street Capital Markets Upgrades Integra LifeSciences (IART) to Buy
Lake Street Capital Markets upgraded Integra LifeSciences (NASDAQ: IART) from Hold to Buy with a price target of $92.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $77.07 yesterday.
